Cargando…
Demyelination as a result of an immune response in patients with COVID-19
The coronavirus disease of 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus-2 (SARS CoV-2), that already appeared as a global pandemic. Presentation of the disease often includes upper respiratory symptoms like dry cough, dyspnea, chest pain, and rhinorrhea that can dev...
Autor principal: | Shabani, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088756/ https://www.ncbi.nlm.nih.gov/pubmed/33934300 http://dx.doi.org/10.1007/s13760-021-01691-5 |
Ejemplares similares
-
The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy
por: Hagen, Kathleen M., et al.
Publicado: (2021) -
Demyelinating strain of mouse hepatitis virus infection bridging innate and adaptive immune response in the induction of demyelination
por: Biswas, Kaushiki, et al.
Publicado: (2016) -
Association of CNS demyelination and COVID-19 infection: an updated systematic review
por: Ismail, Ismail Ibrahim, et al.
Publicado: (2021) -
Role of Demyelination in the Persistence of Neurological and Mental Impairments after COVID-19
por: Khodanovich, Marina Y., et al.
Publicado: (2022) -
A systematic review of cases of CNS demyelination following COVID-19 vaccination
por: Ismail, Ismail Ibrahim, et al.
Publicado: (2022)